The 5th Circuit Court of Appeals recently ruled to temporarily restore a requirement the FDA lifted in 2023 for mifepristone to be dispensed in person, blocking mail-order access, court documents show.

A federal appeals court has restricted access to one of the most common means of abortion in the U.S. by blocking the mailing of mifepristone.

A federal appeals court has restricted access to one of the most common means of abortion in the U.S. by blocking the mailing of mifepristone.